Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations-Reference-Cited by-同舟云学术

Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations

Published:2021-01 Issue: Volume:329 Page:205-222
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Hidalgo Alberto,Garcia-Mouton Cristina,Autilio Chiara,Carravilla Pablo,Orellana Guillermo,Islam Mohammad N.,Bhattacharya Jahar,Bhattacharya Sunita,Cruz Antonio,Pérez-Gil Jesús

Funder

Euskal Herriko Unibertsitatea

Eusko Jaurlaritza

National Institutes of Health

Comunidad de Madrid

Ministerio de Ciencia, Innovación y Universidades

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference72 articles.

1. Pulmonary surfactant pathophysiology: current models and open questions;Perez-Gil;Physiology,2010

2. Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films;Parra;Chem. Phys. Lipids,2015

3. Barrier or carrier? Pulmonary surfactant and drug delivery;Hidalgo;Eur. J. Pharm. Biopharm.,2015

4. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis;Chimote;J Biomed Mater Res B Appl Biomater,2010

5. Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicle;Van’t Veen;Br. J. Pharmacol.,1999

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration;ACS Nano;2024-08-22

2. Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs;European Journal of Pharmaceutical Sciences;2024-05

3. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

4. Polysaccharides screening for pulmonary mucus penetration by molecular dynamics simulation and in vitro verification;International Journal of Biological Macromolecules;2024-04

5. Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants;Journal of Nanobiotechnology;2024-02-27